Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer.
Koh J, Kim S, Woo YD, Song SG, Yim J, Han B, Lim S, Ahn HK, Mun S, Kim JS, Keam B, Kim YA, Lee SH, Jeon YK, Chung DH. Koh J, et al. Among authors: ahn hk. Eur J Cancer. 2022 Oct;174:10-20. doi: 10.1016/j.ejca.2022.07.004. Epub 2022 Aug 12. Eur J Cancer. 2022. PMID: 35970031 Free article.
The wheat NLR pair RXL/Pm5e confers resistance to powdery mildew.
Guo G, Bai K, Hou Y, Gong Z, Zhang H, Wu Q, Lu P, Li M, Dong L, Xie J, Chen Y, Zhang P, Zhu K, Li B, Li W, Dong L, Yang Y, Qiu D, Wang G, Ahn HK, Zhao H, Yuan C, Shi W, Xue M, Yang L, Yu D, Zhao Y, Chen Y, Li H, Hu T, Han GZ, Jones JDG, Liu Z. Guo G, et al. Among authors: ahn hk. Plant Biotechnol J. 2025 Jan 22. doi: 10.1111/pbi.14584. Online ahead of print. Plant Biotechnol J. 2025. PMID: 39840722 Free article.
Use of the Puccinia sorghi haustorial transcriptome to identify and characterize AvrRp1-D recognized by the maize Rp1-D resistance protein.
Kim SB, Kim KT, In S, Jaiswal N, Lee GW, Jung S, Rogers A, Gómez-Trejo LF, Gautam S, Helm M, Ahn HK, Lee HY, Read QD, Woo J, Holan KL, Whitham SA, Jones JDG, Choi D, Dean R, Park E, Balint-Kurti P. Kim SB, et al. Among authors: ahn hk. PLoS Pathog. 2024 Nov 8;20(11):e1012662. doi: 10.1371/journal.ppat.1012662. eCollection 2024 Nov. PLoS Pathog. 2024. PMID: 39514589 Free PMC article.
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.
Penkov K, Bondarenko I, Saenko DV, Kulyaba Y, Guo J, Gong Y, Yamamoto N, Hotko YS, Boyko V, Fadeeva NV, Ursol GM, Ahn HK, Kislov NV, Shen CI, Davis C, Kowalski K, Michelon E, Pavlov D, Hirohashi T, Cho BC. Penkov K, et al. Among authors: ahn hk. Ther Adv Med Oncol. 2024 Sep 11;16:17588359241274592. doi: 10.1177/17588359241274592. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39281971 Free PMC article.
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17).
Kang EJ, Yang Y, Lee S, Kim YJ, Lim SM, Ahn MJ, Choi YJ, Lee Y, Kim TM, Kim I, Ahn HK, Jeung HC, Lee SI, Oh SY, Bae WK, Ryu H, Park KH, Lee KH. Kang EJ, et al. Among authors: ahn hk. ESMO Open. 2024 Sep;9(9):103668. doi: 10.1016/j.esmoop.2024.103668. Epub 2024 Aug 29. ESMO Open. 2024. PMID: 39214049 Free PMC article. Clinical Trial.
290 results